Hot Features
Premium
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Period:
Draw Mode:
| Volume | 195,591 |
|
|||||
| News | - | ||||||
| Day High | 6.92 | Low High |
|||||
| Day Low | 6.485 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Actinium Pharmaceuticals Inc | ATNM | AMEX | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.24 | 3.66% | 6.80 | 17:56:02 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 6.58 | 6.485 | 6.92 | 6.87 | 6.56 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 2,155 | 195,591 | US$ 6.73 | US$ 1,316,650 | - | 4.00 - 9.8599 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 19:00:00 | 10,787 | US$ 6.87 | USD |
Actinium Pharmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 189.43M | 27.41M | - | 81k | -48.82M | -1.78 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Actinium Pharmaceuticals News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ATNM Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 6.64 | 7.43 | 6.47 | 6.86 | 232,137 | 0.16 | 2.41% |
| 1 Month | 7.83 | 9.68 | 6.47 | 8.29 | 339,904 | -1.03 | -13.15% |
| 3 Months | 5.49 | 9.8599 | 5.08 | 8.05 | 365,030 | 1.31 | 23.86% |
| 6 Months | 5.53 | 9.8599 | 4.00 | 6.86 | 279,087 | 1.27 | 22.97% |
| 1 Year | 9.29 | 9.8599 | 4.00 | 7.04 | 237,846 | -2.49 | -26.80% |
| 3 Years | 7.85 | 15.12 | 4.00 | 8.08 | 297,639 | -1.05 | -13.38% |
| 5 Years | 0.295 | 15.12 | 0.1506 | 1.41 | 1,830,709 | 6.51 | 2,205.08% |
Actinium Pharmaceuticals Description
| Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of innovative-targeted therapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest in order to kill those cells safely and effectively. Its most advanced products are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used for hematopoietic stem cells transplantation in various indications and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia. |
